Evaluation of the Safety and Effectiveness of the Bimatoprost Implant System / IOL Combination in Patients With Ocular Hypertension or Mild to Moderate Open-angle Glaucoma
Clinical trial NCT07154797 · COMPLETED
Trial details
- NCT number
- NCT07154797
- Sponsor
- SpyGlass Pharma, Inc.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-21
- Primary completion
- 2022-12-13
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.